Purchases and Sales Made in Q2 2022 in Relmada Therapeutics, Inc. (RLMD)
This table provides information about the institutional ownership of Relmada Therapeutics, Inc. (RLMD) during Q2 2022. The information is specifically focused on institutions that hold shares of RELMADA THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 29, 2022
Q2 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-84.1K- 80.28% |
$1.39M - $2.55M
|
20.7K
$12.4K
|
|
|
Aug 15, 2022
Q2 2022
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-90K- 11.39% |
$1.49M - $2.73M
|
700K
$420K
|
|
|
Aug 05, 2022
Q2 2022
|
Cowen And Company, LLC
|
SELL
|
- |
-97.5K- 8.37% |
$1.61M - $2.96M
|
1.07M
$640K
|
|
|
Aug 11, 2022
Q2 2022
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-138KClosed |
$2.28M - $4.19M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-161K- 57.61% |
$2.66M - $4.89M
|
119K
$71.1K
|
|
|
Aug 15, 2022
Q2 2022
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-178K- 86.41% |
$2.94M - $5.4M
|
28K
$16.8K
|
|
|
Aug 15, 2022
Q2 2022
|
Mangrove Partners
New York, NY |
SELL
|
- |
-258KClosed |
$4.26M - $7.83M
|
0
$0
|